Quality of life in obese patients with type 2 diabetes improved.
Read More »Warfarin with Sulfonylurea Increases Risk of Hypoglycemia Events
National cohort study examined events in Medicare beneficiaries.
Read More »Question #814
You are reviewing lifestyle modifications with a 42-year-old, relatively sedentary patient who has been newly diagnosed with prediabetes. Your screening for any cardiovascular risk factors was negative, so she has agreed to a 3-month trial of dietary modifications and increased physical activity. Structured exercise interventions and modest weight loss have been shown to lower the risk of developing type 2 diabetes in high-risk populations by an average of: (follow link to answer!)
Read More »How Long Does the Insulin Last? Do The Math!
In assessing an in-patient's diabetic educational needs, I was reviewing with him his in-home regimen for his insulin therapy. Per his report, he stated that he took Levemir 50 units twice a day. I asked if it was by needle, syringe and vial preparation, which it was. I instructed him re: the shelf life of Levemir of 42 days once opened. He stated, "I throw it out after a month, but there is always insulin in the vial.” He also said he has more than an adequate supply. He was receiving his insulin by mail-order, receiving as he should, but not using it in a timely fashion. In other words, he was stockpiling his insulin.
Read More »International Textbook of Diabetes Mellitus, 4th Ed., Excerpt #4: Classification of Diabetes Mellitus and Other Categories of Glucose Intolerance Part 4 of 6
There is accumulating evidence supporting an association of certain psychiatric conditions with type 2 diabetes which can be attributed to side-effects of treatment and a high baseline risk of diabetes in this patient group. Diabetes can be induced by the use of atypical antipsychotics including clozapine, olanzapine, risperidone, quetiapine, ziprasidone, and aripiprazole. These drugs have a direct effect of raising blood glucose and also lead to weight gain, [48] which subsequently may increase blood glucose levels.
Read More »Diabetes for Cardiologists Part 3
In this week's Homerun Slides, the natural history of type 2 diabetes and factors contributing to CV risk.
Read More »Dr. Richard Bergman, Parts 5 & 6 – The Diabetes and Obesity Research Institute, Blood Pressure Vs. Blood Glucose
To wrap up this series, we present the final two installments of the conversation between Diabetes in Control Publisher Steve Freed and Dr. Richard Bergman. In part 5, Steve learns more about the institute founded and led by Dr. Bergman at Cedars-Sinai. In part 6, Steve asks what is more important — blood pressure or blood glucose levels?
Read More »Diabetes for Cardiologists Part 2
In this week's Homerun Slides, the vicious circle of hyperinsulinemia in patients with type 2 diabetes.
Read More »The Danger of Assuming a Patient “Knows What to Do”
Female, 41 years of age, A1C 7%, Indian, family history of type 2 diabetes, at least one was insulin-requiring. For unknown reasons, perhaps the fact the patient was a personal trainer and “should have known what to do,” her hcp didn’t put much attention on her A1C, nor was she asked to return for follow up. For various reasons, one of which was not having insurance, she did not return to a hcp for 3 years.
Read More »International Textbook of Diabetes Mellitus, 4th Ed., Excerpt #3: Classification of Diabetes Mellitus and Other Categories of Glucose Intolerance Part 3 of 6
The other specific types of diabetes are less common and can be broadly classed as genetic, exocrine pancreatic, endocrine, and drug-induced causes. A more comprehensive breakdown is provided in Table 1.2 and the more common types are discussed briefly later.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.